Stocks · News reference
Lexaria Bioscience shares are trading higher. The company announced a Material Transfer Agreement with Pegbio to investigate Lexaria's DehydraTECH technology with a proprietary PegBio molecule under development for the GLP-1 industry.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 6:43 PM
- Checked
- Aug 13, 2026, 6:43 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.
Read original at benzinga8-K filing — Lexaria Bioscience Corp. (LEXX)
Filed: 2026-08-17 AccNo: 0001640334-26-001384 Size: 135 KB Item 8.01: Other Events
Read original at edgarLexaria Bioscience Stock Rallies Thursday: What Investors Need to Know
Lexaria Bioscience shares are surging Thursday afternoon after announcing a new Material Transfer Agreement with Hong Kong-listed PegBio.
Read original at benzinga